Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2016 Oct 7;15(12):2936–2945. doi: 10.1158/1535-7163.MCT-16-0354

Figure 6. In vivo effect of VPC-13566 in LNCaP castration resistant xenograft model.

Figure 6

A-The in vivo effect of VPC-13566 on the tumor volume. Data are presented as mean ± SEM of % tumor volume at time of treatment initiation (each group, n=5). B- The in vivo effect of VPC-13566 on PSA level. Data are presented as mean ± SEM of % PSA level at time of treatment initiation (each group, n=5). A p value < 0.05 was considered significant (*) and < 0.01 very significant (**) compared to vehicle control (two-tailed T-Test).